Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2254
Peer-review started: August 4, 2014
First decision: August 27, 2014
Revised: September 22, 2014
Accepted: November 7, 2014
Article in press: November 11, 2014
Published online: February 21, 2015
Processing time: 192 Days and 20.3 Hours
Mixed adenoneuroendocrine carcinoma (MANEC) is a malignant tumor with adenocarcinoma and neuroendocrine components, with ≥ 30% of each component required. MANEC of the ampulla is rare. To the best of our knowledge, only 15 cases of MANEC of the ampulla have been reported in the English-language literature. Here, we report two cases of MANEC of the ampulla in two women aged 43 and 60 years, which was confirmed by histology after pancreaticoduodenectomy. These tumors contained neuroendocrine and adenocarcinoma components. The neuroendocrine components were positive for chromogranin A (CgA), synaptophysin (Syn) and CD56 by immunostaining. The adenocarcinoma components were negative for CgA, Syn and CD56. Both cases were T3N0M0 (Stage IIIA). They survived for 15 and 20 mo after surgery, respectively. A brief discussion about the histopathological features, clinical behavior and treatment of MANEC of ampulla, and review of the relevant literature are presented.
Core tip: The authors report two cases of mixed adenoneuroendocrine carcinoma (MANEC) of the ampulla, which is an extremely rare disease. Both patients received pancreaticoduodenectomy and chemotherapy after surgery. The cases provide a brief discussion about the histopathological features, clinical behavior and treatment of MANEC of the ampulla based on previously published studies.